pixantrone has been researched along with Acute Relapsing Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Debouverie, M; Edan, G; Ferré, JC; Gonsette, R; Sindic, C | 1 |
| Gonsette, RE | 1 |
1 review(s) available for pixantrone and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
A comparison of the benefits of mitoxantrone and other recent therapeutic approaches in multiple sclerosis.
Topics: Adjuvants, Immunologic; Antioxidants; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Administration Schedule; Humans; Immunosuppressive Agents; Isoquinolines; Mitoxantrone; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neuroprotective Agents | 2004 |
1 trial(s) available for pixantrone and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Pixantrone: a B-cell-depleting immunosuppressant for multiple sclerosis patients with active disease.
Topics: Adult; B-Lymphocytes; Female; Humans; Immunosuppressive Agents; Isoquinolines; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Outcome Assessment, Health Care; Topoisomerase II Inhibitors | 2016 |